VANCOUVER, May 9 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today that it has opened a Center for Colorectal Health in Dallas TX. This Center is the Company's first in the Dallas area, one of many new markets that CRH has targeted for expansion. The opening of the Dallas location represents the 5th new Center opened in 2008 bringing the Company's total number of Centers to 13. According to the National Institute of Health, the prevalence rate of hemorrhoids in the US is about 4.4% of the population. Approximately 50% of the U.S. population will develop hemorrhoids by age 50. The Company plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market.

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. CONTACT: Dean Linden, Investor Relations, CRH Medical Corporation at (604) 633-1440 or ir@crhmedcorp.com; Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com or the SEDAR website at http://www.sedar.com